The Food and Drug Administration has given emergency approval to a Trump administration plan to distribute millions of doses of anti-malarial drugs to hospitals across the country, saying it is worth the risk of trying unproven treatments to slow the progression of the disease caused by the novel coronavirus in seriously ill patients.
Share
Comment
Save
The Washington Post is providing this news free to all readers as a public service.
Follow this story and more by signing up for national breaking news email alerts.